The wide diversity of circulating forms of natriuretic peptides makes their accurate blood measurement far more complex than simple 'high means heart failure' interpretations suggest.
20+ years of clinical useDespite two decades of natriuretic peptide testing, the biochemistry and diversity of circulating forms remain incompletely understood
What the researchers found
Despite more than two decades of clinical use, our understanding of natriuretic peptide biochemistry remains incomplete. The circulating forms of natriuretic peptides are far more diverse than initially appreciated, with multiple molecular forms coexisting in plasma. This complexity means that different assays may measure different combinations of these forms, potentially giving inconsistent results.
The simplistic clinical model — that elevated NP values directly indicate heart failure severity and predict prognosis — is insufficient. A deeper understanding of how the NP system works, including the processing, degradation, and clearance of different peptide forms, is needed for correct interpretation of results in cardiovascular practice.
Why it matters
Natriuretic peptide tests are among the most commonly ordered cardiac biomarkers worldwide, used daily in emergency departments and cardiology clinics. If these tests are being interpreted too simplistically — or if different assays are measuring different molecular forms — patients could receive incorrect diagnoses or inappropriate treatment decisions. Understanding these analytical nuances is essential for improving cardiac care.
How the study worked
Narrative review summarizing recent advances in understanding the biochemistry of the natriuretic peptide system, the diversity of circulating peptide forms, and the analytical challenges these present for clinical assays. The review integrates findings from biochemical, clinical, and analytical studies.
What this study cannot tell us
This is a narrative review without new experimental data. The authors rely on previously published studies with varying methodologies. The review was published in 2016, and some analytical issues may have been addressed by newer assay platforms. Specific recommendations for improved testing are limited.
How to read the evidence
This is a narrative review that synthesizes existing literature on natriuretic peptide biochemistry and analytical challenges. It provides important conceptual insights but does not generate new experimental or clinical data.
When this study was published
Published in 2016, some analytical issues discussed may have been partially addressed by newer assay platforms. However, the fundamental biochemical complexity of natriuretic peptides remains relevant to current clinical practice.
The bigger picture
As natriuretic peptide testing becomes ever more central to heart failure management and guideline-directed therapy, the analytical accuracy of these tests has enormous downstream consequences. This review highlights a gap between the biochemical complexity of the NP system and the simplistic way results are often interpreted, calling for better standardization and more nuanced clinical application.
Questions still open
- Should natriuretic peptide assays be standardized to measure specific molecular forms rather than total immunoreactive peptide?
- How much clinical misclassification results from current oversimplified interpretation of NP levels?
- Could next-generation assays targeting specific NP forms improve diagnostic accuracy for heart failure subtypes?
Common questions
What are natriuretic peptides and why are they tested?
Why might my natriuretic peptide test result be misleading?
Read the original research
Analytical Issues with Natriuretic Peptides - has this been Overly Simplified?
EJIFCC, 27(3), 189-207
Citation
Semenov, Alexander G; Katrukha, Alexey G. (2016). Analytical Issues with Natriuretic Peptides - has this been Overly Simplified?. EJIFCC, 27(3), 189-207.